105 related articles for article (PubMed ID: 38729129)
1. The Efficacy of Three Different Oral Hygiene Regimens in Preventing Chemotherapy-Induced Oral Mucositis in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation.
Aygunes U; Karagun BS; Sasmaz I; Antmen B
Klin Padiatr; 2024 May; 236(3):180-188. PubMed ID: 38729129
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced mucositis: a randomized clinical trial of micronized sucralfate versus salt & soda mouthwashes.
Dodd MJ; Miaskowski C; Greenspan D; MacPhail L; Shih AS; Shiba G; Facione N; Paul SM
Cancer Invest; 2003; 21(1):21-33. PubMed ID: 12643006
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Effect of Polaprezinc, a Zinc-L-carnosine, Against Chemotherapy-induced Oral Mucositis in Pediatric Patients Undergoing Autologous Stem Cell Transplantation.
Funato M; Ozeki M; Suzuki A; Ishihara M; Kobayashi R; Nozawa A; Yasue S; Endo-Ohnishi S; Fukao T; Itoh Y
Anticancer Res; 2018 Aug; 38(8):4691-4697. PubMed ID: 30061237
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of two different oral hygiene regimens on the incidence and severity of oral mucositis in pediatric patients receiving hematopoietic stem cell transplantation: A prospective interventional study.
Mubaraki S; Pani SC; Alseraihy A; Abed H; Alkhayal Z
Spec Care Dentist; 2020 Nov; 40(6):566-573. PubMed ID: 32964512
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of treatment to relieve mucositis-induced discomfort.
Turhal NS; Erdal S; Karacay S
Support Care Cancer; 2000 Jan; 8(1):55-8. PubMed ID: 10650899
[TBL] [Abstract][Full Text] [Related]
6. Use of sodium hyaluronate and synthetic amino acid precursors of collagen for the symptomatic treatment of mucositis in patients undergoing haematopoietic stem cell transplants.
Ruggiero T; Pol R; Camisassa D; Arata V; Martino I; Giaccone L; Carossa S
J Biol Regul Homeost Agents; 2016; 30(3):889-894. PubMed ID: 27655517
[TBL] [Abstract][Full Text] [Related]
7. Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT).
Vitale MC; Modaffari C; Decembrino N; Zhou FX; Zecca M; Defabianis P
Lasers Med Sci; 2017 Aug; 32(6):1423-1428. PubMed ID: 28664389
[TBL] [Abstract][Full Text] [Related]
8. Treatment of symptomatic oral mucositis with sodium hyaluronate and synthetic amino acid precursors of collagen in patients undergoing haematopoietic stem cell transplantation.
Ruggiero T; Pol R; Camisassa D; Simiele S; Giaccone L; Carossa S
J Biol Regul Homeost Agents; 2018; 32(3):737-743. PubMed ID: 29921408
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Sucralfate Mouth Wash in Prevention of 5-fluorouracil Induced Oral Mucositis: A Prospective, Randomized, Double-Blind, Controlled Trial.
Ala S; Saeedi M; Janbabai G; Ganji R; Azhdari E; Shiva A
Nutr Cancer; 2016; 68(3):456-63. PubMed ID: 27007594
[TBL] [Abstract][Full Text] [Related]
10. Supersaturated Calcium Phosphate Rinse in Prevention and Treatment of Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplant.
Bhatt N; Naithani R; Gupta SK
Exp Clin Transplant; 2017 Oct; 15(5):567-570. PubMed ID: 28229803
[TBL] [Abstract][Full Text] [Related]
11. Polaprezinc prevents oral mucositis in patients treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation.
Hayashi H; Kobayashi R; Suzuki A; Ishihara M; Nakamura N; Kitagawa J; Kanemura N; Kasahara S; Kitaichi K; Hara T; Tsurumi H; Moriwaki H; Itoh Y
Anticancer Res; 2014 Dec; 34(12):7271-7. PubMed ID: 25503160
[TBL] [Abstract][Full Text] [Related]
12. Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi-institutional randomized controlled trial.
Kitagawa J; Kobayashi R; Nagata Y; Kasahara S; Ono T; Sawada M; Ohata K; Kato-Hayashi H; Hayashi H; Shimizu M; Itoh Y; Tsurumi H; Suzuki A
Int J Cancer; 2021 Mar; 148(6):1462-1469. PubMed ID: 32984946
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation.
Mori T; Hasegawa K; Okabe A; Tsujimura N; Kawata Y; Yashima T; Kobayashi N; Kondo S; Aisa Y; Kato J; Tsunoda K; Nagai T; Nakagawa T; Shigematsu N; Kubo A; Ikeda Y; Okamoto S
Int J Hematol; 2008 Dec; 88(5):583-587. PubMed ID: 18972188
[TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis.
Dodd MJ; Dibble SL; Miaskowski C; MacPhail L; Greenspan D; Paul SM; Shiba G; Larson P
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Jul; 90(1):39-47. PubMed ID: 10884634
[TBL] [Abstract][Full Text] [Related]
15. Randomized control trial of benzydamine HCl versus sodium bicarbonate for prophylaxis of concurrent chemoradiation-induced oral mucositis.
Chitapanarux I; Tungkasamit T; Petsuksiri J; Kannarunimit D; Katanyoo K; Chakkabat C; Setakornnukul J; Wongsrita S; Jirawatwarakul N; Lertbusayanukul C; Sripan P; Traisathit P
Support Care Cancer; 2018 Mar; 26(3):879-886. PubMed ID: 28942587
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of sodium bicarbonate and zinc chloride mouthwashes in the treatment of oral mucositis and quality of life in patients with cancer under chemotherapy.
Mohammadi F; Oshvandi K; Kamallan SR; Khazaei S; Ranjbar H; Ahmadi-Motamayel F; Gillespie M; Jenabi E; Vafaei SY
Nurs Open; 2022 May; 9(3):1602-1611. PubMed ID: 35170247
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Plantago major, chlorhexidine 0.12% and sodium bicarbonate 5% solution in the treatment of oral mucositis in cancer patients with solid tumour: A feasibility randomised triple-blind phase III clinical trial.
Cabrera-Jaime S; Martínez C; Ferro-García T; Giner-Boya P; Icart-Isern T; Estrada-Masllorens JM; Fernández-Ortega P
Eur J Oncol Nurs; 2018 Feb; 32():40-47. PubMed ID: 29353631
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD.
Sugita J; Matsushita T; Kashiwazaki H; Kosugi M; Takahashi S; Wakasa K; Shiratori S; Ibata M; Shono Y; Shigematsu A; Obara M; Fujimoto K; Endo T; Nishio M; Kondo T; Hashino S; Tanaka J; Asaka M; Imamura M
Bone Marrow Transplant; 2012 Feb; 47(2):258-64. PubMed ID: 21423118
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant.
Beaven AW; Shea TC
Drugs Today (Barc); 2007 Jul; 43(7):461-73. PubMed ID: 17728847
[TBL] [Abstract][Full Text] [Related]
20. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
